Literature DB >> 594

[Computer experience and further developments in the respiratory function laboratory (author's transl)].

R Schindl, K Mayer, K Aigner.   

Abstract

Reported is on satisfactory results obtained with a small-size computer consisting of punching and scanning device, as well as plain writing machine in the respiratory function laboratory. Developed in on- as well as off-line processing by an own technical staff, a diagnostic and teaching program was established for all respiratory function routine methods with the advantages of a large number of cases examined, elimination of sources of error, considerable supply of data and information, automatic documentation and filing, plain writing, interpretation and evaluation of findings. In continuation of such works also the blood gas analysis has been included. These values as the total of disturbances of the pathophysiological acid-base status are considered and interpreted. Clinical correction is forced in this man-machine dialogue by automatic stops of the whole machinery before going on. Subsequently and in addition are computer alveolar-arterial oxygen pressure gradient, venous shunt and oxygen saturation and expressed utilizing the capacity of the small-size computer. Further developments in the respiratory function diagnostic- and teaching program for small-size computers--not too expensive in the building block principle - are intended.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 594

Source DB:  PubMed          Journal:  Med Klin        ISSN: 0025-8458


  59 in total

Review 1.  Medicinal chemistry of fetal hemoglobin inducers for treatment of beta-thalassemia.

Authors:  Roberto Gambari; Eitan Fibach
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

2.  Safety, tolerability, and pharmacokinetics of PTC124, a nonaminoglycoside nonsense mutation suppressor, following single- and multiple-dose administration to healthy male and female adult volunteers.

Authors:  Samit Hirawat; Ellen M Welch; Gary L Elfring; Valerie J Northcutt; Sergey Paushkin; Seongwoo Hwang; Eileen M Leonard; Neil G Almstead; William Ju; Stuart W Peltz; Langdon L Miller
Journal:  J Clin Pharmacol       Date:  2007-04       Impact factor: 3.126

3.  Naturally occurring utrophin correlates with disease severity in Duchenne muscular dystrophy.

Authors:  Kleopas A Kleopa; Anthi Drousiotou; Eleni Mavrikiou; Annita Ormiston; Theodoros Kyriakides
Journal:  Hum Mol Genet       Date:  2006-04-04       Impact factor: 6.150

Review 4.  Molecular basis of muscular dystrophies.

Authors:  R D Cohn; K P Campbell
Journal:  Muscle Nerve       Date:  2000-10       Impact factor: 3.217

Review 5.  Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy.

Authors:  Andrew T Hattersley; Frances M Ashcroft
Journal:  Diabetes       Date:  2005-09       Impact factor: 9.461

Review 6.  Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we?

Authors:  Pedro Miura; Bernard J Jasmin
Journal:  Trends Mol Med       Date:  2006-01-27       Impact factor: 11.951

7.  PTC124 targets genetic disorders caused by nonsense mutations.

Authors:  Ellen M Welch; Elisabeth R Barton; Jin Zhuo; Yuki Tomizawa; Westley J Friesen; Panayiota Trifillis; Sergey Paushkin; Meenal Patel; Christopher R Trotta; Seongwoo Hwang; Richard G Wilde; Gary Karp; James Takasugi; Guangming Chen; Stephen Jones; Hongyu Ren; Young-Choon Moon; Donald Corson; Anthony A Turpoff; Jeffrey A Campbell; M Morgan Conn; Atiyya Khan; Neil G Almstead; Jean Hedrick; Anna Mollin; Nicole Risher; Marla Weetall; Shirley Yeh; Arthur A Branstrom; Joseph M Colacino; John Babiak; William D Ju; Samit Hirawat; Valerie J Northcutt; Langdon L Miller; Phyllis Spatrick; Feng He; Masataka Kawana; Huisheng Feng; Allan Jacobson; Stuart W Peltz; H Lee Sweeney
Journal:  Nature       Date:  2007-04-22       Impact factor: 49.962

8.  Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.

Authors:  Mary-Claire King; Joan H Marks; Jessica B Mandell
Journal:  Science       Date:  2003-10-24       Impact factor: 47.728

Review 9.  Pharmacological strategies for muscular dystrophy.

Authors:  Tejvir S Khurana; Kay E Davies
Journal:  Nat Rev Drug Discov       Date:  2003-05       Impact factor: 84.694

Review 10.  Gene therapy for severe combined immunodeficiency: are we there yet?

Authors:  Marina Cavazzana-Calvo; Alain Fischer
Journal:  J Clin Invest       Date:  2007-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.